Announced
Completed
Financials
Tags
Venture Capital
Completed
Acquisition
synthetic fibres
Friendly
Biotechnology
Private Equity
France
Cross Border
Private
biotechnology company
Minority
Single Bidder
Synopsis
Danaher Corporation, Agilent Technologies, Life Sciences Partners, Casdin Capital, Illumina Ventures, Bpifrance and Merck Ventures invested $89m Series B funding round in DNA Script, a biotechnology company. “The SYNTAX EDS system was inspired by the wide availability of in-lab and benchtop next-generation sequencing systems and the impact they have had on genomics research and personalized medicine. This first-of-its-kind DNA printer makes writing DNA as simple and straightforward as reading DNA is currently, meaning that research and clinical labs will be able to do same-day synthesis of oligonucleotides, saving precious time when it comes to iterating experiments or developing diagnostic or confirmatory tools," Thomas Ybert, DNA Script CEO and Co-Founder.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.